Free Trial
NASDAQ:LFMD

LifeMD Q2 2025 Earnings Report

LifeMD logo
$11.78 -0.19 (-1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$11.88 +0.11 (+0.89%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeMD EPS Results

Actual EPS
N/A
Consensus EPS
-$0.02
Beat/Miss
N/A
One Year Ago EPS
N/A

LifeMD Revenue Results

Actual Revenue
N/A
Expected Revenue
$66.17 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

LifeMD Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

LifeMD Earnings Headlines

LifeMD: An Overlooked GLP-1 Beneficiary
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
LifeMD: Getting Frothy
See More LifeMD Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like LifeMD? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LifeMD and other key companies, straight to your email.

About LifeMD

LifeMD (NASDAQ:LFMD) (NASDAQ: LFMD) is a telehealth company headquartered in Boca Raton, Florida, offering a digital platform for primary care and specialist consultations. Founded in 2016, the company went public in 2021 through a merger with a special purpose acquisition company. LifeMD’s platform connects patients to U.S.-licensed clinicians through video visits, secure messaging and tailored care plans, with a focus on improving access to healthcare across the country.

The company’s core services center on men’s health, including treatment for erectile dysfunction, hair loss, hormone replacement therapy and weight management. In addition, LifeMD provides primary care services—such as preventive screenings, chronic condition management and lab testing—delivered via at-home sample kits or through partner laboratories. Mental health support is also available through counseling and psychiatric evaluations, reflecting the company’s broader vision of integrating physical and behavioral health.

LifeMD has grown both organically and through strategic acquisitions, enhancing its clinical offerings and pharmacy capabilities. The company maintains partnerships with nationwide compounding pharmacies and diagnostic laboratories to facilitate fast prescription fulfillment and streamline lab work. Its technology infrastructure is designed to support personalized treatment plans and ongoing patient engagement, driving adherence and improving health outcomes.

Led by CEO Phil Bane, a veteran of the digital health sector, LifeMD’s leadership team includes seasoned executives in medical, technology and regulatory affairs. The company serves patients in all 50 states, leveraging a scalable telehealth model to address the evolving needs of a modern patient population. By combining clinical expertise with digital innovation, LifeMD aims to deliver convenient, cost‐effective and high-quality care to individuals seeking personalized health solutions.

View LifeMD Profile

More Earnings Resources from MarketBeat